428 related articles for article (PubMed ID: 15163715)
1. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
[TBL] [Abstract][Full Text] [Related]
2. Virus attachment and replication are promoted after acquisition of host CD28 and CD152 by HIV-1.
Giguere JF; Diou J; Madrenas J; Tremblay MJ
J Infect Dis; 2005 Oct; 192(7):1265-8. PubMed ID: 16136471
[TBL] [Abstract][Full Text] [Related]
3. Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation.
Esser MT; Graham DR; Coren LV; Trubey CM; Bess JW; Arthur LO; Ott DE; Lifson JD
J Virol; 2001 Jul; 75(13):6173-82. PubMed ID: 11390619
[TBL] [Abstract][Full Text] [Related]
4. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M
J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824
[TBL] [Abstract][Full Text] [Related]
5. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
Mitra RS; Judge TA; Nestle FO; Turka LA; Nickoloff BJ
J Immunol; 1995 Mar; 154(6):2668-77. PubMed ID: 7533180
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice.
Van Parijs L; Sethna MP; Schweitzer AN; Borriello F; Sharpe AH; Abbas AK
J Immunol; 1997 Dec; 159(11):5336-44. PubMed ID: 9548473
[TBL] [Abstract][Full Text] [Related]
7. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
8. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
9. The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication.
Barker E; Bossart KN; Fujimura SH; Levy JA
Cell Immunol; 1999 Sep; 196(2):95-103. PubMed ID: 10527561
[TBL] [Abstract][Full Text] [Related]
10. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.
Höllsberg P; Scholz C; Anderson DE; Greenfield EA; Kuchroo VK; Freeman GJ; Hafler DA
J Immunol; 1997 Nov; 159(10):4799-805. PubMed ID: 9366404
[TBL] [Abstract][Full Text] [Related]
11. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ
Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381
[TBL] [Abstract][Full Text] [Related]
12. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory molecules in ocular cicatricial pemphigoid.
Tesavibul N; Dorfman D; Sangwan VS; Christen W; Panayotis Z; Rojas B; Foster CS
Invest Ophthalmol Vis Sci; 1998 May; 39(6):982-8. PubMed ID: 9579477
[TBL] [Abstract][Full Text] [Related]
14. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
[TBL] [Abstract][Full Text] [Related]
15. CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice.
Mathur M; Herrmann K; Qin Y; Gulmen F; Li X; Krimins R; Weinstock J; Elliott D; Bluestone JA; Padrid P
Am J Respir Cell Mol Biol; 1999 Oct; 21(4):498-509. PubMed ID: 10502560
[TBL] [Abstract][Full Text] [Related]
16. Interactions of CD80 and CD86 with CD28 and CTLA4.
Ellis JH; Burden MN; Vinogradov DV; Linge C; Crowe JS
J Immunol; 1996 Apr; 156(8):2700-9. PubMed ID: 8609386
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors.
Short JJ; Pereboev AV; Kawakami Y; Vasu C; Holterman MJ; Curiel DT
Virology; 2004 May; 322(2):349-59. PubMed ID: 15110532
[TBL] [Abstract][Full Text] [Related]
18. CD28/CTLA-4 ligands: the gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23.
Fernández-Ruiz E; Somoza C; Sánchez-Madrid F; Lanier LL
Eur J Immunol; 1995 May; 25(5):1453-6. PubMed ID: 7539761
[TBL] [Abstract][Full Text] [Related]
19. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
20. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures.
Döpper S; Wilflingseder D; Prodinger WM; Stiegler G; Speth C; Dierich MP; Stoiber H
Eur J Immunol; 2003 Aug; 33(8):2098-107. PubMed ID: 12884283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
